Article
Strategic Amyotrophic Lateral Sclerosis Australia-Systems Genomics Consortium (SALSA-SGC): cohort profile.
BMJ open - 18 Jun 2026
Henders Anjali K, Ziser Laura, Garton Fleur C, Adams Lorel, Ernst Karalyn, Furlong Sarah, Heads Judith Anne, Heggie Susan, Krasniqi Ruth, Bhadravathi Lokeshappa Madhura, Mazumder Srestha, McNamara Elyshia, MacShane Amanda, Mekhael Linda, Nunn Lorelle, Orden Bronwen, Ryder Julie, Thorpe Kathryn, Toubia Marie, Wallace Leanne M, Wickremeratne Dina, Windebank Emma, Benyamin Beben, Ngo Shyuan, Nicholson Garth, Pamphlett Roger, Steyn Frederik J, Visscher Peter M, Willams Kelly L, Henderson Robert, Kiernan Matthew C, Laing Nigel, Mathers Susan, McCombe Pamela A, Needham Merrilee, Rowe Dominic, Schultz David, Talman Paul, Vucic Steve, Blair Ian P, McRae Allan F, Wray Naomi R
Abstract excerpt
PURPOSE: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative motor neuron disease (MND) with heterogeneity in disease onset, progression and treatment response. The Strategic ALS Australia-Systems Genomics Consortium (SALSA-SGC) was established in recognition of the need for large data sets of clinical data matched with biological samples to enable and foster ALS research and better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.